IP Library Granted Patent US 9,272,051
Granted Patent B2
US 9,272,051 · App. 14/320,159 · Granted Mar 1, 2016

Methods and systems for modulating hormones and related methods, agents and compositions

Inventors: William A. Goddard, III (Pasadena, CA); Mark Menna (Los Angeles, CA); Stephen Pandol (Los Angeles, CA); Ravinder Abrol (Arcadia, CA)
Assignees: California Institute of Technology; The Regents of the University of California; The United States Government Represented by the Department of Veterans Affairs
A61K47/4823A61K31/10A61K31/12A61K31/122A61K31/167A61K31/17A61K31/205A61K31/352A61K31/353A61K31/365A61K31/4375A61K31/4745A61K31/513A61K31/704A61K31/7016G01N33/566
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,272,051
App. No.
14/320,159
Granted
Mar 1, 2016
Kind
B2
Abstract

Provided herein are bitter taste receptor ligands, related agents, combinations, compositions, methods and systems for modulating release of a metabolic hormone in vitro or in vivo from cells of the GI tract of an individual.

Claims (5)

1. A composition comprising a combination of 6-n-propylthiouracil and a complementary molecule, wherein the complementary molecule interferes with systemic absorption and release of 6-n-propylthiouracil upon enteral administration, wherein the complementary molecule is polyethylene glycol, wherein the polyethylene glycol is conjugated to the 6-n-propylthiouracil, and wherein the combination results in prolonged activation of bitter taste receptors in the gut.

2. The composition of claim 1 , wherein 6-n-propylthiouracil comprises a propyl group, and the complementary molecule is attached to the propyl group.

3. The composition of claim 1 , wherein the polyethylene glycol has a molecular weight (M r ) of at least about 10,000 g/mol.

4. A composition comprising a combination of 6-n-propylthiouracil and a complementary molecule, wherein the complementary molecule interferes with systemic absorption and release of 6-n-propylthiouracil upon enteral administration, wherein the complementary molecule is cellulose, wherein the cellulose is conjugated to the 6-n-propylthiouracil, and wherein the combination results in prolonged activation of bitter taste receptors in the gut.

5. The composition of claim 4 , wherein 6-n-propylthiouracil comprises a propyl group, and the complementary molecule is attached to the propyl group.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 20, 2014
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033573/0579 →
Continuity (3)
Continuation 13163638 · Jun 17, 2011
Provisional Application 61397940 · Jun 17, 2010
Related Publication 20140364387A1 · Dec 11, 2014